Posted:
10/2/2024, 1:13:58 PM
Location(s):
Texas, United States ⋅ Dallas, Texas, United States
Experience Level(s):
Senior
Field(s):
Consulting
Workplace Type:
Remote
Who We Are:
ReCode Therapeutics is a clinical-stage genetic medicines company using precision delivery to power the next wave of mRNA and gene correction therapeutics. ReCode’s proprietary Selective Organ Targeting (SORT) lipid nanoparticle (LNP) platform enables highly precise and targeted delivery of genetic medicines directly to the organs, tissues and cells implicated in disease, enabling improved efficacy and potency. ReCode’s lead programs include RCT1100 for the treatment of primary ciliary dyskinesia caused by pathogenic mutations in the DNAI1 gene, and RCT2100 for the treatment of the 10-13% of cystic fibrosis patients who have Class I mutations in the CFTR gene and do not respond to currently approved CFTR modulators. RCT1100 and RCT2100 are inhaled disease-modifying mRNA-based therapies formulated using the SORT LNP delivery platform. ReCode is expanding its pipeline to develop potential therapies for other rare and common genetic diseases, including musculoskeletal, central nervous system, liver and infectious disease indications.
Summary of Position:
We are seeking an enthusiastic and experienced Senior Clinical Research Associate Consultant for ReCode’s RCT2100 CF program. You are a self-motivated team player that supports study team to implement clinical operations strategy for ReCode’s RCT2100 CF program. You will be responsible for collaborating with Clinical Operations and cross-functional teams to deliver on ReCode’s mission of powering the next wave of genetic medicines. You will have substantial experience in either rare diseases or genetic medicines such as mRNA, gene therapy or gene editing
Responsibilities:
Qualifications:
Salary Range: $50-$65/hr
*Please note that for remote positions, salary may be adjusted for cost of living
Benefits Offered for Full-Time Employees:
ReCode Therapeutics (www.recodetx.com) offers a competitive compensation/benefits package with a friendly, collaborative culture that values employee engagement and ongoing career development.
ReCode Therapeutics is an Equal Opportunity Employer.
Website: https://recodetx.com/
Headquarter Location: Dallas, Texas, United States
Employee Count: 51-100
Year Founded: 2015
IPO Status: Private
Last Funding Type: Series B
Industries: Biopharma ⋅ Biotechnology ⋅ Genetics ⋅ Pharmaceutical